title: Déjà vu all over again: skin cap still contains a high-potency glucocorticosteroid.
authors.forename: David L
authors.initials: DL
authors.lastname: Swanson
authors.forename: Mark R
authors.initials: MR
authors.lastname: Pittelkow
authors.forename: Linda M
authors.initials: LM
authors.lastname: Benson
authors.forename: Adam M
authors.initials: AM
authors.lastname: Hawkridge
authors.forename: David C
authors.initials: DC
authors.lastname: Muddiman
mesh_terms: D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000009:adverse effects* / Q000737:chemistry* / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008422:Materials Testing; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012680:Sensitivity and Specificity
chemical_list: D000305:Adrenal Cortex Hormones; D003879:Dermatologic Agents